fda glp-1 enforcement news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounded GLP-1s are entering a

Obesity also covers a wide range of systemic issues like insulin resistance due to increased weight gain and expression of inflammatory cytokines

Florida Surgery & Weight Loss Center offers affordable self-pay treatment options for eligible patients

The right plan will usually have no deductible on your expensive drug, so coverage starts right away

Phenotypic switching in diabetic gastroparesis: mechanism directs therapy

When gut bacteria ferment fibre in the colon, they produce short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate, which directly stimulate GLP-1 release from intestinal L-cells

How Much Protein Do I Need